September 01, 2014 10:39 PM ET

Biotechnology

Company Overview of Callisto Pharmaceuticals, Inc.

Executive Profile

Gabriele M. Cerrone

Founder and Executive Chairman, Tiziana Life Sciences PLC
AgeTotal Calculated CompensationThis person is connected to 3 Board Members in 3 different organizations across 7 different industries.

See Board Relationships
42--

Background

Mr. Gabriel M. Cerrone is the Founder and Executive Chairman of Tiziana Life Sciences PLC and GENSIGNIA. Mr. Cerrone is a sole General Partner of Panetta Partners, Ltd. He is a Co-Founder and Chairman of Arna Therapeutics and BioVitas Capital. He served as Consultant of Callisto Pharmaceuticals, Inc. since January 2005 and Xenomics Inc. since June 27, 2005. He co-founded FermaVir Pharmaceuticals. He has a successful track record and extensive experience in the seeding, ...

Corporate Headquarters

420 Lexington Avenue
New York, New York 10170

United States

Phone: 212-297-0010
Fax: 212-297-0020

Board Members Memberships

Former Chairman
Chairman and Consultant
Former Co-Chairman and Consultant
Former Chairman and Member of Senior Executive Selection & Oversight Committee
Founder and Executive Chairman
2001-N/A
Former Director
2005-Present
Chairman and Member of Senior Executive Selection & Oversight Committee
2007-2012
Former Director
2008-N/A
Former Chairman
2010-N/A
Former Director

Education

Unknown/Other Education
New York University - Leonard N. Stern School of Business
Bachelor's Degree
New York University - Leonard N. Stern School of Business

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Callisto Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.